Maiden Pharmaceuticals, whose was linked to the deaths of at least 66 children in The Gambia in 2022, is back under a new name. The Union Health Minister gave the company a clean chit, contradicting tests in three countries and the WHO. A Gambian court case filed by victim families continues, albeit without the company's participation. On to one of the most absurd corporate pivots in recent memory. Allbirds, the company once beloved by Silicon Valley, has sold its entire brand and is reinventing itself as an AI cloud computing provider. It is keeping its listed company shell, renaming it NewBird AI, and raising $50 million to buy GPUs. Scientists at Texas A&M have developed a that, in just two doses, reduced brain inflammation and significantly improved memory in aging mice. The effects lasted months. Researchers say it could eventually help treat Alzheimer's, though we're still at the mouse stage. is easily the most famous New Yorker of Indian-Ugandan origin, but his earnings from music royalties, accrued from a past life as a multilingual rapper "Young Cardamom," were a measly $1,643 last year. His fans tell him they are listening to his music. They clearly aren't. This Sunday is Bicycle Day, the anniversary of Swiss chemist Albert Hofmann's famous 1943 ride home after taking 0.25 mg of , the compound he had synthesised five years earlier. He thought he had taken a low dose, only for the full effects to hit him mid-pedal, in what he later called a terrifying ride.